ERA 2026: HighTide Therapeutics Presents New Findings Supporting HTD1801's Renoprotective Potential in Oral Presentation

Harian Intens 1 jam yang lalu
176
ERA 2026: HighTide Therapeutics Presents New Findings Supporting HTD1801's Renoprotective Potential in Oral Presentation
Bacakan Artikel

Intens.id,

 HighTide Therapeutics, Inc. (2511.HK), an innovative biopharmaceutical company specializing in the development of ...
Baca Juga
Rekomendasi
Read More

Post Tags